These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7689109)

  • 21. Synthesis and evaluation of 2-pyridinone derivatives as HIV-1 specific reverse transcriptase inhibitors. 1. Phthalimidoalkyl and -alkylamino analogues.
    Hoffman JM; Wai JS; Thomas CM; Levin RB; O'Brien JA; Goldman ME
    J Med Chem; 1992 Oct; 35(21):3784-91. PubMed ID: 1279172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lead optimization at C-2 and N-3 positions of thiazolidin-4-ones as HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Murugesan V; Tiwari VS; Saxena R; Tripathi R; Paranjape R; Kulkarni S; Makwana N; Suryawanshi R; Katti SB
    Bioorg Med Chem; 2011 Nov; 19(22):6919-26. PubMed ID: 21982685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and anti-HIV-1 activity of a series of imidazo[1,5-b]pyridazines.
    Livermore DG; Bethell RC; Cammack N; Hancock AP; Hann MM; Green DV; Lamont RB; Noble SA; Orr DC; Payne JJ
    J Med Chem; 1993 Nov; 36(24):3784-94. PubMed ID: 7504733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, biochemical, and antiviral evaluations of C6 benzyl and C6 biarylmethyl substituted 2-hydroxylisoquinoline-1,3-diones: dual inhibition against HIV reverse transcriptase-associated RNase H and polymerase with antiviral activities.
    Vernekar SK; Liu Z; Nagy E; Miller L; Kirby KA; Wilson DJ; Kankanala J; Sarafianos SG; Parniak MA; Wang Z
    J Med Chem; 2015 Jan; 58(2):651-64. PubMed ID: 25522204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel 1,3-dihydro-benzimidazol-2-ones and their analogues as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Monforte AM; Logoteta P; De Luca L; Iraci N; Ferro S; Maga G; De Clercq E; Pannecouque C; Chimirri A
    Bioorg Med Chem; 2010 Feb; 18(4):1702-10. PubMed ID: 20097079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pyrrolobenzoxazepinone derivatives as non-nucleoside HIV-1 RT inhibitors: further structure-activity relationship studies and identification of more potent broad-spectrum HIV-1 RT inhibitors with antiviral activity.
    Campiani G; Morelli E; Fabbrini M; Nacci V; Greco G; Novellino E; Ramunno A; Maga G; Spadari S; Caliendo G; Bergamini A; Faggioli E; Uccella I; Bolacchi F; Marini S; Coletta M; Nacca A; Caccia S
    J Med Chem; 1999 Oct; 42(21):4462-70. PubMed ID: 10543890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
    Yang SS; Fliakas-Boltz V; Bader JP; Buckheit RW
    Leukemia; 1995 Oct; 9 Suppl 1():S75-85. PubMed ID: 7475321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological evaluation of certain alkenyldiarylmethanes as anti-HIV-1 agents which act as non-nucleoside reverse transcriptase inhibitors.
    Cushman M; Golebiewski WM; Graham L; Turpin JA; Rice WG; Fliakas-Boltz V; Buckheit RW
    J Med Chem; 1996 Aug; 39(16):3217-27. PubMed ID: 8759644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of stereo and regiochemistry towards wild and multidrug resistant HIV-1 virus: viral potency of chiral PETT derivatives.
    Venkatachalam TK; Mao C; Uckun FM
    Biochem Pharmacol; 2004 May; 67(10):1933-46. PubMed ID: 15130770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indolyl aryl sulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: role of two halogen atoms at the indole ring in developing new analogues with improved antiviral activity.
    Regina GL; Coluccia A; Piscitelli F; Bergamini A; Sinistro A; Cavazza A; Maga G; Samuele A; Zanoli S; Novellino E; Artico M; Silvestri R
    J Med Chem; 2007 Oct; 50(20):5034-8. PubMed ID: 17803291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substituted indoles as HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent evaluation (WO2015044928).
    Li X; Gao P; Zhan P; Liu X
    Expert Opin Ther Pat; 2016 May; 26(5):629-35. PubMed ID: 26742549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. (3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro-1H-indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase.
    Meleddu R; Distinto S; Corona A; Bianco G; Cannas V; Esposito F; Artese A; Alcaro S; Matyus P; Bogdan D; Cottiglia F; Tramontano E; Maccioni E
    Eur J Med Chem; 2015 Mar; 93():452-60. PubMed ID: 25728026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase.
    Williams TM; Ciccarone TM; MacTough SC; Rooney CS; Balani SK; Condra JH; Emini EA; Goldman ME; Greenlee WJ; Kauffman LR
    J Med Chem; 1993 Apr; 36(9):1291-4. PubMed ID: 7683725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thiazolinone analogues of indolmycin with antiviral and antibacterial activity.
    Harnden MR; Bailey S; Boyd MR; Taylor DR; Wright ND
    J Med Chem; 1978 Jan; 21(1):82-7. PubMed ID: 619151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bis(heteroaryl)piperazine (BHAP) reverse transcriptase inhibitors: structure-activity relationships of novel substituted indole analogues and the identification of 1-[(5-methanesulfonamido-1H-indol-2-yl)-carbonyl]-4-[3- [(1-methylethyl)amino]-pyridinyl]piperazine monomethanesulfonate (U-90152S), a second-generation clinical candidate.
    Romero DL; Morge RA; Genin MJ; Biles C; Busso M; Resnick L; Althaus IW; Reusser F; Thomas RC; Tarpley WG
    J Med Chem; 1993 May; 36(10):1505-8. PubMed ID: 7684450
    [No Abstract]   [Full Text] [Related]  

  • 36. Design, synthesis, docking studies and biological screening of 2-thiazolyl substituted -2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazines as potent HIV-1 reverse transcriptase inhibitors.
    Gawali R; Trivedi J; Bhansali S; Bhosale R; Sarkar D; Mitra D
    Eur J Med Chem; 2018 Sep; 157():310-319. PubMed ID: 30099253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 11: structural modulations of diaryltriazines with potent anti-HIV activity.
    Xiong YZ; Chen FE; Balzarini J; De Clercq E; Pannecouque C
    Eur J Med Chem; 2008 Jun; 43(6):1230-6. PubMed ID: 17869386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological evaluation of 2-thioxopyrimidin-4(1H)-one derivatives as potential non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Khalifa NM; Al-Omar MA
    Int J Mol Sci; 2014 Nov; 15(11):20723-35. PubMed ID: 25397597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2-(Aryl)-3-furan-2-ylmethyl-thiazolidin-4-ones as selective HIV-RT inhibitors.
    Rawal RK; Prabhakar YS; Katti SB; De Clercq E
    Bioorg Med Chem; 2005 Dec; 13(24):6771-6. PubMed ID: 16198576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New pyridinone derivatives as potent HIV-1 nonnucleoside reverse transcriptase inhibitors.
    Le Van K; Cauvin C; de Walque S; Georges B; Boland S; Martinelli V; Demonté D; Durant F; Hevesi L; Van Lint C
    J Med Chem; 2009 Jun; 52(12):3636-43. PubMed ID: 19469474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.